"Orthomyxoviridae" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of RNA viruses causing INFLUENZA and other diseases. There are five recognized genera: INFLUENZAVIRUS A; INFLUENZAVIRUS B; INFLUENZAVIRUS C; ISAVIRUS; and THOGOTOVIRUS.
| Descriptor ID |
D009975
|
| MeSH Number(s) |
B04.820.545
|
| Concept/Terms |
Orthomyxoviridae- Orthomyxoviridae
- Orthomyxoviruses
- Orthomyxovirus
- Influenza Viruses
- Influenza Virus
|
Below are MeSH descriptors whose meaning is more general than "Orthomyxoviridae".
Below are MeSH descriptors whose meaning is more specific than "Orthomyxoviridae".
This graph shows the total number of publications written about "Orthomyxoviridae" by people in this website by year, and whether "Orthomyxoviridae" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 2 | 0 | 2 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2020 | 3 | 1 | 4 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Orthomyxoviridae" by people in Profiles.
-
Edgar JE, Trezise S, Anthony RM, Krammer F, Palese P, Ravetch JV, Bournazos S. Antibodies elicited in humans upon chimeric hemagglutinin-based influenza virus vaccination confer Fc?R-dependent protection in vivo. Proc Natl Acad Sci U S A. 2023 10 31; 120(44):e2314905120.
-
Bournazos S, Corti D, Virgin HW, Ravetch JV. Fc-optimized antibodies elicit CD8 immunity to viral respiratory infection. Nature. 2020 12; 588(7838):485-490.
-
Balachandran S, Rall GF. Benefits and Perils of Necroptosis in Influenza Virus Infection. J Virol. 2020 04 16; 94(9).
-
Carta MG, Orr? G, Scano A, Coghe F, Nunnari G, Facchini G, Numis FG, Berretta M. In the face of the SARS-CoV-2 outbreak, do people suffering from oncological disease need specific attention? Eur Rev Med Pharmacol Sci. 2020 04; 24(7):3434-3436.
-
Cho KJ, Ishido S, Eisenlohr LC, Roche PA. Activation of Dendritic Cells Alters the Mechanism of MHC Class II Antigen Presentation to CD4 T Cells. J Immunol. 2020 03 15; 204(6):1621-1629.
-
Wang TT, Bournazos S, Ravetch JV. Immunological responses to influenza vaccination: lessons for improving vaccine efficacy. Curr Opin Immunol. 2018 08; 53:124-129.
-
Bournazos S, Ravetch JV. Attenuated Vaccines for Augmented Immunity. Cell Host Microbe. 2017 03 08; 21(3):314-315.
-
Eisenlohr LC. Alternative generation of MHC class II-restricted epitopes: not so exceptional? Mol Immunol. 2013 Sep; 55(2):169-71.
-
Squires RB, Noronha J, Hunt V, Garc?a-Sastre A, Macken C, Baumgarth N, Suarez D, Pickett BE, Zhang Y, Larsen CN, Ramsey A, Zhou L, Zaremba S, Kumar S, Deitrich J, Klem E, Scheuermann RH. Influenza research database: an integrated bioinformatics resource for influenza research and surveillance. Influenza Other Respir Viruses. 2012 Nov; 6(6):404-16.
-
Eisenlohr LC, Luckashenak N, Apcher S, Miller MA, Sinnathamby G. Beyond the classical: influenza virus and the elucidation of alternative MHC class II-restricted antigen processing pathways. Immunol Res. 2011 Dec; 51(2-3):237-48.